BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Verstockt B, Parkes M, Lee J. How Do We Predict a Patient's Disease Course and Whether They Will Respond to Specific Treatments? Gastroenterology 2022:S0016-5085(21)04081-6. [PMID: 34995535 DOI: 10.1053/j.gastro.2021.12.245] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Solitano V, Armuzzi A. Editorial: STAT3 phosphorylation for tofacitinib monitoring in ulcerative colitis-a step towards precision medicine? Aliment Pharmacol Ther 2022;56:347-8. [PMID: 35748839 DOI: 10.1111/apt.17038] [Reference Citation Analysis]
2 Bourgonje AR, Vogl T, Segal E, Weersma RK. Antibody signatures in inflammatory bowel disease: current developments and future applications. Trends in Molecular Medicine 2022. [DOI: 10.1016/j.molmed.2022.05.004] [Reference Citation Analysis]
3 Verstockt B, Bressler B, Martinez-Lozano H, McGovern D, Silverberg MS. Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management? Gastroenterology 2022;162:1370-82. [PMID: 34995534 DOI: 10.1053/j.gastro.2021.12.246] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Swaminathan A, Fan D, Borichevsky GM, Mules TC, Hirschfeld E, Frampton CM, Day AS, Siegel CA, Gearry RB. The disease severity index for inflammatory bowel disease is associated with psychological symptoms, quality of life and predicts a more complicated disease course. Aliment Pharmacol Ther 2022. [PMID: 35633043 DOI: 10.1111/apt.17058] [Reference Citation Analysis]
5 Alsoud D, Verstockt B, Vermeire S. Letter: immunogenicity is not the root cause for loss of response to anti-TNF agents in patients with IBD in TDM era. Aliment Pharmacol Ther 2022;55:885-6. [PMID: 35315101 DOI: 10.1111/apt.16797] [Reference Citation Analysis]
6 Raine T, Danese S. Breaking Through the Therapeutic Ceiling: What Will It Take? Gastroenterology 2022:S0016-5085(21)04080-4. [PMID: 34995533 DOI: 10.1053/j.gastro.2021.09.078] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]